Pluri (PLUR) Institutional Ownership → Obama’s Forever Term [exposed] (From Porter & Company) (Ad) Free PLUR Stock Alerts $6.12 +0.03 (+0.49%) (As of 05/16/2024 ET) Add Compare Share Share OwnershipStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for Pluri (NASDAQ:PLUR)CurrentInstitutional OwnershipPercentage16.59%Number ofInstitutional Buyers(last 12 months)2TotalInstitutional Inflows(last 12 months)$761.89KNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$123.84K Get PLUR Insider Trade Alerts Want to know when executives and insiders are buying or selling Pluri stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data PLUR Institutional Buying and Selling by Quarter Ad Porter & CompanyObama’s Forever Term [exposed]America’s Last Election New documentary, America’s Last Election, reveals the true (and terrifying) story of how the D.C. establishment has engineered a brutal new crisis that could hand them permanent power. Power they will use to reshape America to their dark, dystopian vision.Start streaming it now at no cost here Pluri Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails11/8/2023 Values First Advisors Inc.135,547$81K0.1%+168.4%0.328% 8/11/2023 Nia Impact Advisors LLC38,294$29K0.0%-33.5%0.093% 7/6/2023 Green Alpha Advisors LLC114,970$92K0.1%+92.1%0.280% 5/11/2023 Meitav Investment House Ltd.82,673$86K0.0%N/A0.208% 5/5/2023 Prime Capital Investment Advisors LLC57,862$59K0.0%N/A0.145% 5/3/2023 Nia Impact Advisors LLC57,595$59K0.0%-41.4%0.145% 2/9/2023 Nia Impact Advisors LLC98,313$92K0.1%-26.1%0.301% 12/2/2022 Values First Advisors Inc.48,330$38K0.0%N/A0.148% 10/14/2022 Green Alpha Advisors LLC56,226$44K0.0%N/A0.172% (Data available from 1/1/2016 forward) PLUR Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of PLUR shares? During the previous two years, the following institutional investors and hedge funds held shares of Pluri shares: Green Alpha Advisors LLC ($92K), Meitav Investment House Ltd. ($86K), Values First Advisors Inc. ($81K), and Prime Capital Investment Advisors LLC ($59K), Nia Impact Advisors LLC ($29K).Learn more on PLUR's institutional investors. What percentage of Pluri stock is owned by institutional investors? 16.59% of Pluri stock is owned by institutional investors. Learn more on PLUR's institutional investor holdings. Which institutional investors have been buying Pluri stock? The following institutional investors have purchased Pluri stock in the last 24 months: Values First Advisors Inc. ($133.37K), Green Alpha Advisors LLC ($111.36K), Meitav Investment House Ltd. ($82.67K), and Prime Capital Investment Advisors LLC ($57.86K). How much institutional buying is happening at Pluri? Institutional investors have bought a total of 385,258 shares in the last 24 months. This purchase volume represents approximately $2.56M in transactions. Which Pluri major shareholders have been selling company stock? The following institutional investors have sold Pluri stock in the last 24 months: Nia Impact Advisors LLC ($94.65K). How much institutional selling is happening at Pluri? Institutional investors have sold a total of 94,653 shares in the last 24 months. This volume of shares sold represents approximately $716.57K in transactions. Related Companies: Surrozen Institutional Ownership NKGen Biotech Institutional Ownership MiNK Therapeutics Institutional Ownership Protara Therapeutics Institutional Ownership Achilles Therapeutics Institutional Ownership CASI Pharmaceuticals Institutional Ownership Brainstorm Cell Therapeutics Institutional Ownership Estrella Immunopharma Institutional Ownership SAB Biotherapeutics Institutional Ownership Quince Therapeutics Institutional Ownership This page (NASDAQ:PLUR) was last updated on 5/17/2024 by MarketBeat.com Staff From Our PartnersInvest in the "Trojan Horse" of Alzheimer's TreatmentBehind the MarketsObama’s Forever Term [exposed]Porter & CompanyGold Set to EXPLODE!Gold Safe ExchangeThe 1,000X Crypto PlaybookTrue Market InsidersUrgent Nvidia WarningAltimetryCharles Payne Demystifies OptionsUnstoppable ProsperityBiden FINISHED On June 13th?Paradigm PressWhy Is Gold On a MASSIVE rally? Huge Alerts Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pluri Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.